Trial Profile
Phase I trial of ELND 005 in volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Jan 2010
Price :
$35
*
At a glance
- Drugs ELND 005 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Transition Therapeutics
- 30 Aug 2007 Status change from initiated to completed
- 14 Aug 2007 New trial record.